Key result
Machine learning models predict 6-month readmission in comorbid COPD and HF with ~0.76 AUC.
Why the study?
Predicting 6-month readmission risk in hospitalized patients with comorbid COPD and heart failure using machine learning models was needed to improve risk stratification.
Observational (n=1,291)
Effect estimate: AUC 0.756 (Random Forest) and 0.733 (LightGBM)
Machine learning models, particularly Random Forest and LightGBM, can effectively predict the risk of 6-month readmission in patients with comorbid heart failure and COPD using key clinical features like NT-proBNP and troponin-T.
ML models may aid 6-month readmission risk stratification in COPD-HF; leaves open prospective validation before clinical use.
Objectives This study aimed to develop and validate machine learning models for predicting 6-month readmission risk in hospitalized patients with comorbid COPD and heart failure. Methods This study utilized data from the MIMIC-IV database (version 3.1). Adult inpatients with concurrent diagnoses of COPD and HF were included. Seven ML algorithms were employed to develop predictive models for 6-month readmission risk. Model overall performance was evaluated using the area under the receiver operating characteristic curve (ROC), decision curve analysis (DCA), precision-recall curves (PRC), and calibration curves. SHAP (SHapley Additive exPlanations) analysis was applied to interpret the top-performing models. Results A total of 1,291 patients were included in the analysis. The Random Forest (RF) and Light Gradient Boosting Machine (LightGBM) models respectively demonstrated the best predictive performance, with AUCs of 0.756 and 0.733 on the test set. SHAP analysis revealed that NT-proBNP, pH, neutrophil count, Troponin-T, and comorbid diabetes were the top five features contributing most to the models’ predictions. Interpretation The RF and LightGBM models developed in this study can effectively identify patients with COPD and HF who are at high risk for readmission within six months. These models, coupled with the SHAP-based interpretability framework, could aid clinicians in risk stratification and guide targeted interventions for this high-risk population.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) conducted an observational in Comorbid COPD and heart failure (n=1,291). Machine learning prediction models was evaluated on 6-month readmission risk (AUC 0.756 (Random Forest) and 0.733 (LightGBM)). Random Forest and LightGBM models predicted 6-month readmission risk in patients with comorbid COPD and heart failure, achieving AUCs of 0.756 and 0.733 on the test set, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: